Clinical trial
The Efficacy of Xuebijing Injection in Adult Patients With Sepsis
NCT03238742 is registered in ClinicalTrials.gov with Southeast University, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy of Xuebijing Injection in Adult Patients With Sepsis
- Lead sponsor
- Southeast University, China
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 20, 2017
- Completion date
- January 8, 2020
- Enrollment
- 1,817 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.